Los Angeles County
US braces for continued surge in coronavirus cases, hospitalisations
As newly reported cases of the coronavirus continued to spike across much of the United States, breaking records for hospitalisations, some local leaders are moving to enact more stringent restrictions. US officials had pleaded with Americans to avoid travel and limit social gatherings as the nation entered its winter holiday season. But many appear to have disregarded those pleas over the long Thanksgiving weekend as the Transportation Security Administration screened nearly 1.2 million airline passengers on Sunday, the highest since mid-March. That number is still about 60 percent lower than the comparable day last year when 2.88 million passengers were screened, the highest ever recorded by the agency. Health officials say they are now preparing for a wave of cases over the next two or ...
Probe demanded over Latino police shooting death in Los Angeles
Los Angeles officials Tuesday demanded an independent probe into the death of a young Latino security guard, whose shooting by police has fueled more protests against police brutality and racism. Andres Guardado, 18, was killed last week after a deputy fired multiple gunshots in Gardena, Los Angeles County. Police say Guardado was shot when he fled from an auto repair shop after he “produced a handgun.” Guardado’s death came during a period of nationwide demonstrations that began with the death in police custody of an African American man, George Floyd, in Minnesota last month. Los Angeles County’s board of supervisors Tuesday unanimously approved a motion for a “robust and independent investigation to ensure the truth is uncovered and justice is served.” A day earlier, Los Angeles Sheriff...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
